Status:
ACTIVE_NOT_RECRUITING
Improving Informed Decision Making for Cancer Clinical Trial Participation
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Educational Problems
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to develop and pilot test a multi-communication approach to improve informed decision-making about cancer Clinical Trials (CTs) participation by increasing awareness of CTs a...
Detailed Description
The proposed two-year study involves a randomized controlled educational trial featuring a 2-group parallel cohort design with random assignment of 400 cancer patients from the MCC to the intervention...
Eligibility Criteria
Inclusion
- Newly diagnosed cancer patients (within 1 year) attending any of the clinics at the MCC
- Patients who have not participated in a Clinical Trial before
- English or Spanish-speaking
- Able to provide informed consent
Exclusion
- Younger than 18 years
- Patients who have already had a consultation with their doctor to discuss treatment options
- Patients who have participated in a Clinical Trial before
- Unable to provide informed consent
Key Trial Info
Start Date :
February 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
581 Patients enrolled
Trial Details
Trial ID
NCT03820687
Start Date
February 8 2023
End Date
December 31 2026
Last Update
March 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center San Antonio, MCC
San Antonio, Texas, United States, 78229